Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

University of Toronto

$123,443.00

Development of a magnetic resonance imaging and image-analysis framework for high-precision gamma knife-based stereotactic radiosurgery of brain tumours

EF 2018-19

Résumé
Brain metastasis is a common complication of cancer, occurring in 20-40% of all cancer patients. *The standard of care for patients presenting with a limited number of brain metastases is stereotactic radiosurgery (SRS). SRS delivers a high, precisely-focused, single dose of radiation to a target region. Sunnybrook has recently installed a new image-guided dedicated device for SRS of brain tumours (Gamma Knife Perfexion; Elekta, Montreal, Canada).*Despite advancements in our ability to precisely deliver high radiation doses to target regions, there is still an urgent need to improve upon our current methods to guide radiation, to determine which patients would benefit from SRS, and to assess response of tumours to radiation early after treatment. To address these shortcomings, this project aims to develop and optimize a novel magnetic resonance (MR) imaging and image-processing framework for high-precision personalized SRS of metastatic brain tumours with Gamma Knife technology.*In SRS treatment, MRI is used to delineate the tumour target. However, these images are commonly distorted, which can result in a ""geometric miss"" and ineffective treatment, especially in the case of small metastatic targets. Geometrically accurate MRI solutions will be developed for radiotherapy planning. These will be complemented by new MRI scans of tumour metabolism, to more accurately delineate treatment targets. In combination with these imaging methods, new image-processing techniques (referred to as ""radiomics"") will be used to develop and optimize models to predict response prior to or early after a treatment. Such prediction can help clinicians deliver effective adjuvant therapies, or change ineffective treatments before it is potentially too late.*In collaboration with industrial partner Elekta, the MRI and radiomics platform developed in this project can be incorporated into the commercial SRS treatment planning system. The novel technologies will assist clinical decision making and improve marketability of the products.*
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
507521-2016
Name nom
SadeghiNaini, Ali
Department département
Medical Biophysics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2016
Award amount
123443
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Development of a magnetic resonance imaging and image-analysis framework for high-precision gamma knife-based stereotactic radiosurgery of brain tumours
Keyword
NSERC
Application summary
Brain metastasis is a common complication of cancer, occurring in 20-40% of all cancer patients. *The standard of care for patients presenting with a limited number of brain metastases is stereotactic radiosurgery (SRS). SRS delivers a high, precisely-focused, single dose of radiation to a target region. Sunnybrook has recently installed a new image-guided dedicated device for SRS of brain tumours (Gamma Knife Perfexion; Elekta, Montreal, Canada).*Despite advancements in our ability to precisely deliver high radiation doses to target regions, there is still an urgent need to improve upon our current methods to guide radiation, to determine which patients would benefit from SRS, and to assess response of tumours to radiation early after treatment. To address these shortcomings, this project aims to develop and optimize a novel magnetic resonance (MR) imaging and image-processing framework for high-precision personalized SRS of metastatic brain tumours with Gamma Knife technology.*In SRS treatment, MRI is used to delineate the tumour target. However, these images are commonly distorted, which can result in a ""geometric miss"" and ineffective treatment, especially in the case of small metastatic targets. Geometrically accurate MRI solutions will be developed for radiotherapy planning. These will be complemented by new MRI scans of tumour metabolism, to more accurately delineate treatment targets. In combination with these imaging methods, new image-processing techniques (referred to as ""radiomics"") will be used to develop and optimize models to predict response prior to or early after a treatment. Such prediction can help clinicians deliver effective adjuvant therapies, or change ineffective treatments before it is potentially too late.*In collaboration with industrial partner Elekta, the MRI and radiomics platform developed in this project can be incorporated into the commercial SRS treatment planning system. The novel technologies will assist clinical decision making and improve marketability of the products.*